Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors

Trends in Microbiology

Volumn 21, Issue 8, 2013, Pages 430-441

  Raymond, Benoit ^a   Young, Joanna C ^a   Pallett, Mitchell ^a   Endres, Robert G ^a   Clements, Abigail ^a   Frankel, Gad ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cell survival modulation; Enteropathogens; Inflammatory response manipulation; Phagocytosis remodeling; Subversion of cellular trafficking; T3SS

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; CELL SURVIVAL; CELL TRANSPORT; ENDOSOME; ENTEROPATHOGENIC ESCHERICHIA COLI; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SALMONELLA; SHIGELLA; TYPE III SECRETION SYSTEM; YERSINIA;

CELL SURVIVAL MODULATION; ENTEROPATHOGENS; INFLAMMATORY RESPONSE MANIPULATION; PHAGOCYTOSIS REMODELING; SUBVERSION OF CELLULAR TRAFFICKING; T3SS;

ANIMALS; APOPTOSIS; ENDOSOMES; ENTEROBACTERIACEAE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; MAP KINASE SIGNALING SYSTEM; MEMBRANE TRANSPORT PROTEINS; NF-KAPPA B; PHAGOCYTOSIS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; VIRULENCE FACTORS;

ESCHERICHIA COLI; SALMONELLA; SHIGELLA; YERSINIA;

EID: 84881029343     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.06.008     Document Type: Review

References (110)

1. Bulgin R., et al. Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors. Infect. Immun. 2010, 78:1417-1425.
2. Faini M., et al. Vesicle coats: structure, function, and general principles of assembly. Trends Cell Biol. 2013, 23:279-288.
3. Kim J., et al. Biogenesis of γ-secretase early in the secretory pathway. J. Cell Biol. 2007, 179:951-963.
4. Thanabalasuriar A., et al. Sec24 interaction is essential for localization and virulence-associated function of the bacterial effector protein NleA. Cell. Microbiol. 2012, 14:1206-1218.
5. Mundy R., et al. Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates. J. Med. Microbiol. 2004, 53:1145-1149.
6. Thanabalasuriar A., et al. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell. Microbiol. 2010, 12:31-41.
7. Olsen R.L., et al. The enterohemorrhagic Escherichia coli effector protein NleF binds mammalian Tmp21. Vet. Microbiol. 2013, 64:164-170.
8. Selyunin A.S., et al. The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold. Nature 2011, 469:107-111.
9. Clements A., et al. EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function. Cell. Microbiol. 2011, 13:1429-1439.
10. Dong N., et al. Structurally distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to counteract host defenses. Cell 2012, 150:1029-1041.
11. Germane K.L., Spiller B.W. Structural and functional studies indicate that the EPEC effector, EspG, directly binds p21-activated kinase. Biochemistry 2011, 50:917-919.
12. Burnaevskiy N., et al. Proteolytic elimination of N-myristoylmodifications by the Shigella virulence factor IpaJ. Nature 2013, 496:106-109.
13. Nichols C.D., Casanova J.E. Salmonella-directed recruitment of new membrane to invasion foci via the host exocyst complex. Curr. Biol. 2010, 20:1316-1320.
14. Meresse S., et al. Controlling the maturation of pathogen-containing vacuoles: a matter of life and death. Nat. Cell Biol. 1999, 1:E183-E188.
15. Meresse S., et al. The rab7 GTPase controls the maturation of Salmonella typhimurium-containing vacuoles in HeLa cells. EMBO J. 1999, 18:4394-4403.
16. McGourty K., et al. Salmonella inhibits retrograde trafficking of mannose-6-phosphate receptors and lysosome function. Science 2012, 338:963-967.
17. Drecktrah D., et al. Salmonella trafficking is defined by continuous dynamic interactions with the endolysosomal system. Traffic 2007, 8:212-225.
18. Drecktrah D., et al. Dynamic behavior of Salmonella-induced membrane tubules in epithelial cells. Traffic 2008, 9:2117-2129.
19. Rajashekar R., et al. Dynamic remodeling of the endosomal system during formation of Salmonella-induced filaments by intracellular Salmonella enterica. Traffic 2008, 9:2100-2116.
20. Blocker A., et al. The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes. J. Cell Biol. 1999, 147:683-693.
21. High N., et al. IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J. 1992, 11:1991-1999.
22. Fernandez-Prada C.M., et al. Shigella flexneri IpaH(7.8) facilitates escape of virulent bacteria from the endocytic vacuoles of mouse and human macrophages. Infect. Immun. 2000, 68:3608-3619.
23. Mounier J., et al. Rho family GTPases control entry of Shigella flexneri into epithelial cells but not intracellular motility. J. Cell Sci. 1999, 112:2069-2080.
24. Zhou D., Galan J. Salmonella entry into host cells: the work in concert of type III secreted effector proteins. Microbes Infect. 2001, 3:1293-1298.
25. Marcus S.L., et al. Salmonella enterica serovar Typhimurium effector SigD/SopB is membrane-associated and ubiquitinated inside host cells. Cell. Microbiol. 2002, 4:435-446.
26. Ramel D., et al. Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling. Sci. Signal. 2011, 4:ra61.
27. Niebuhr K., et al. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 2002, 21:5069-5078.
28. Peiser L., et al. Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect. Immun. 2000, 68:1953-1963.
29. Anderson C.L., et al. Phagocytosis mediated by three distinct Fcγ receptor classes on human leukocytes. J. Exp. Med. 1990, 171:1333-1345.
30. Ross G.D., et al. Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes. J. Leukoc. Biol. 1992, 51:109-117.
31. Isberg R.R. Pathways for the penetration of enteroinvasive Yersinia into mammalian cells. Mol. Biol. Med. 1990, 7:73-82.
32. Bulgin R., et al. The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals. PLoS Pathog. 2009, 5:e1000683.
33. Martinez-Argudo I., et al. Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system. Cell. Microbiol. 2007, 9:1538-1546.
34. Goosney D.L., et al. Enteropathogenic Escherichia coli inhibits phagocytosis. Infect. Immun. 1999, 67:490-495.
35. Black D.S., et al. Identification of an amino-terminal substrate-binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets. Mol. Microbiol. 1998, 29:1263-1274.
36. de la Puerta M.L., et al. Characterization of new substrates targeted by Yersinia tyrosine phosphatase YopH. PLoS ONE 2009, 4:e4431.
37. Hamid N., et al. YopH dephosphorylates Cas and Fyn-binding protein in macrophages. Microb. Pathog. 1999, 27:231-242.
38. Persson C., et al. The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J. 1997, 16:2307-2318.
39. Weidow C.L., et al. CAS/Crk signalling mediates uptake of Yersinia into human epithelial cells. Cell. Microbiol. 2000, 2:549-560.
40. Von Pawel-Rammingen U., et al. GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol. Microbiol. 2000, 36:737-748.
41. Andor A., et al. YopE of Yersinia, a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endothelial cells. Cell. Microbiol. 2001, 3:301-310.
42. Roppenser B., et al. Yersinia enterocolitica differentially modulates RhoG activity in host cells. J. Cell Sci. 2009, 122:696-705.
43. Prehna G., et al. Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors. Cell 2006, 126:869-880.
44. Groves E., et al. Sequestering of Rac by the Yersinia effector YopO blocks Fcγ receptor-mediated phagocytosis. J. Biol. Chem. 2010, 285:4087-4098.
45. Shao F., et al. Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:904-909.
46. Dong N., et al. A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis. EMBO J. 2010, 29:1363-1376.
47. Iizumi Y., et al. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. Cell Host Microbe 2007, 2:383-392.
48. Marches O., et al. EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis. Cell. Microbiol. 2008, 10:1104-1115.
49. Quitard S., et al. The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting. Cell. Microbiol. 2006, 8:972-981.
50. Peralta-Ramirez J., et al. EspF interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability. Infect. Immun. 2008, 76:3854-3868.
51. Alto N.M., et al. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. J. Cell Biol. 2007, 178:1265-1278.
52. Taylor R.C., et al. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008, 9:231-241.
53. Hemrajani C., et al. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3129-3134.
54. Clark C.S., Maurelli A.T. Shigella flexneri inhibits staurosporine-induced apoptosis in epithelial cells. Infect. Immun. 2007, 75:2531-2539.
55. Bergounioux J., et al. Calpain activation by the Shigella flexneri effector VirA regulates key steps in the formation and life of the bacterium's epithelial niche. Cell Host Microbe 2012, 11:240-252.
56. Blasche S., et al. The E. coli effector protein NleF is a caspase inhibitor. PLoS ONE 2013, 8:e58937.
57. Knodler L.A., et al. The Salmonella effector protein SopB protects epithelial cells from apoptosis by sustained activation of Akt. J. Biol. Chem. 2005, 280:9058-9064.
58. Jones R.M., et al. Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 2008, 3:233-244.
59. Nougayrede J.P., Donnenberg M.S. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell. Microbiol. 2004, 6:1097-1111.
60. Samba-Louaka A., et al. The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells. Infect. Immun. 2009, 77:5471-5477.
61. Wong A.R., et al. The interplay between the Escherichia coli Rho guanine nucleotide exchange factor effectors and the mammalian RhoGEF inhibitor EspH. mBio 2012, 3. e00250-11, http://dx.doi.org/10.1128/mBio.00250-11.
62. Jesenberger V., et al. Salmonella-induced caspase-2 activation in macrophages: a novel mechanism in pathogen-mediated apoptosis. J. Exp. Med. 2000, 192:1035-1046.
63. Nadler C., et al. The type III secretion effector NleE inhibits NF-κB activation. PLoS Pathog. 2010, 6:e1000743.
64. Newton H.J., et al. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-κB p65. PLoS Pathog. 2010, 6:e1000898.
65. Vossenkamper A., et al. Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE. J. Immunol. 2010, 185:4118-4127.
66. Gao X., et al. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation. Cell Host Microbe 2013, 13:87-99.
67. Yen H., et al. NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA. PLoS Pathog. 2010, 6:e1001231.
68. Pham T.H., et al. Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2. Infect. Immun. 2012, 80:2133-2140.
69. Gao X., et al. Bacterial effector binding to ribosomal protein s3 subverts NF-κB function. PLoS Pathog. 2009, 5:e1000708.
70. Ruchaud-Sparagano M.H., et al. The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors. PLoS Pathog. 2011, 7:e1002414.
71. Yan D., et al. Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs. Nat. Immunol. 2012, 13:1063-1071.
72. Kim D.W., et al. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:14046-14051.
73. Zhou Y., et al. The Shigella type three secretion system effector OspG directly and specifically binds to host ubiquitin for activation. PLoS ONE 2013, 8:e57558.
74. Singer A.U., et al. Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases. Nat. Struct. Mol. Biol. 2008, 15:1293-1301.
75. Ashida H., et al. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKγ to dampen the host NF-κB-mediated inflammatory response. Nat. Cell Biol. 2010, 12:66-73.
76. Sanada T., et al. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature 2012, 483:623-626.
77. Viboud G.I., et al. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection. Cell. Microbiol. 2006, 8:1504-1515.
78. Orth K., et al. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 2000, 290:1594-1597.
79. Paquette N., et al. Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:12710-12715.
80. Le Negrate G., et al. Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-κB, suppresses IκBα ubiquitination and modulates innate immune responses. J. Immunol. 2008, 180:5045-5056.
81. Haraga A., Miller S.I. A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-κB-dependent gene expression. Infect. Immun. 2003, 71:4052-4058.
82. Collier-Hyams L.S., et al. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-κB pathway. J. Immunol. 2002, 169:2846-2850.
83. Zhang Y.L., Dong C. MAP kinases in immune responses. Cell. Mol. Immunol. 2005, 2:20-27.
84. Baruch K., et al. Metalloprotease type III effectors that specifically cleave JNK and NF-κB. EMBO J. 2011, 30:221-231.
85. Sham H.P., et al. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation. Infect. Immun. 2011, 79:3552-3562.
86. Rohde J.R., et al. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 2007, 1:77-83.
87. Li H., et al. The phosphothreonine lyase activity of a bacterial type III effector family. Science 2007, 315:1000-1003.
88. Arbibe L., et al. An injected bacterial effector targets chromatin access for transcription factor NF-κB to alter transcription of host genes involved in immune responses. Nat. Immunol. 2007, 8:47-56.
89. Sauvonnet N., et al. YopH prevents monocyte chemoattractant protein 1 expression in macrophages and T-cell proliferation through inactivation of the phosphatidylinositol 3-kinase pathway. Mol. Microbiol. 2002, 45:805-815.
90. Orth K., et al. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 1999, 285:1920-1923.
91. Bruno V.M., et al. Salmonella Typhimurium type III secretion effectors stimulate innate immune responses in cultured epithelial cells. PLoS Pathog. 2009, 5:e1000538.
92. Keestra A.M., et al. Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Nature 2013, 496:233-237.
93. Stecher B., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007, 5:2177-2189.
94. Lopez C.A., et al. Phage-mediated acquisition of a type III secreted effector protein boosts growth of salmonella by nitrate respiration. MBio 2012, 3. e00143-12, http://dx.doi.org/10.1128/mBio.00143-12.
95. Winter S.E., et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010, 467:426-429.
96. Raymond B., et al. The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-κB-dependent manner. Cell. Microbiol. 2011, 13:1881-1893.
97. Fukazawa A., et al. GEF-H1 mediated control of NOD1 dependent NF-κB activation by Shigella effectors. PLoS Pathog. 2008, 4:e1000228.
98. Keestra A.M., et al. A Salmonella virulence factor activates the NOD1/NOD2 signaling pathway. mBio 2011, 2. e00266-11, http://dx.doi.org/10.1128/mBio.00266-11.
99. Bergsbaken T., et al. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 2009, 7:99-109.
100. Mariathasan S., et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430:213-218.
101. Muller A.J., et al. The S. Typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. Cell Host Microbe 2009, 6:125-136.
102. Miao E.A., et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3076-3080.
103. Perez-Lopez A., et al. Salmonella downregulates Nod-like receptor family CARD domain containing protein 4 expression to promote its survival in B cells by preventing inflammasome activation and cell death. J. Immunol. 2013, 190:1201-1209.
104. Hersh D., et al. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:2396-2401.
105. Hilbi H., et al. Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J. Biol. Chem. 1998, 273:32895-32900.
106. Zhang Y., et al. Inhibition of MAPK and NF-κB pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J. Immunol. 2005, 174:7939-7949.
107. Philip N.H., Brodsky I.E. Cell death programs in Yersinia immunity and pathogenesis. Front. Cell. Infect. Microbiol. 2012, 2:149.
108. Brodsky I.E., et al. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 2010, 7:376-387.
109. Schotte P., et al. Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1β. J. Biol. Chem. 2004, 279:25134-25142.
110. LaRock C.N., Cookson B.T. The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing. Cell Host Microbe 2012, 12:799-805.